
Enapotamab
CAS No. 1912423-61-0
Enapotamab( —— )
Catalog No. M36748 CAS No. 1912423-61-0
Enapotamab is an AXL/UFO-related antibody that can be used to synthesize antibody-drug couplings (Enapotamab Vedotin).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 400 | Get Quote |
![]() ![]() |
5MG | 654 | Get Quote |
![]() ![]() |
10MG | 1026 | Get Quote |
![]() ![]() |
25MG | 1454 | Get Quote |
![]() ![]() |
50MG | 1978 | Get Quote |
![]() ![]() |
100MG | 2601 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEnapotamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnapotamab is an AXL/UFO-related antibody that can be used to synthesize antibody-drug couplings (Enapotamab Vedotin).
-
DescriptionEnapotamab is an anti-AXL/UFO reference antibody. Enapotamab can be used to synthesis Bcl-xl inhibitor antibody-drug conjugates.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetTAM Receptor
-
RecptorTAM Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1912423-61-0
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Matthew T. Burger, et al. Bcl-xl inhibitor antibody-drug conjugates and methods of use thereof. WO2022115477A1.
molnova catalog



related products
-
DS-1205
DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro and tumor growth in vivo.
-
Enapotamab
Enapotamab is an AXL/UFO-related antibody that can be used to synthesize antibody-drug couplings (Enapotamab Vedotin).
-
Glesatinib hydrochlo...
Glesatinib (MGCD-265) is a tyrosine kinase inhibitor that potently and selectively inhibits Met and Axl kinase.